Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 589

1.

Next-Generation Cell-active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.

Lazo JS, Blanco IK, Tasker NR, Rastelli EJ, Burnett JC, Garrott SR, Hart DJ, McCloud RL, Hsu KL, Wipf P, Sharlow ER.

J Pharmacol Exp Ther. 2019 Oct 10. pii: jpet.119.262188. doi: 10.1124/jpet.119.262188. [Epub ahead of print]

2.

Myocardial Aging, the Cardiac Atria, and BNP: What Does it All Mean?

Burnett JC Jr, Ma X, McKie PM.

J Am Coll Cardiol. 2019 Oct 8;74(14):1801-1803. doi: 10.1016/j.jacc.2019.08.020. No abstract available.

PMID:
31582140
3.

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Arendse LB, Danser AHJ, Poglitsch M, Touyz RM, Burnett JC Jr, Llorens-Cortes C, Ehlers MR, Sturrock ED.

Pharmacol Rev. 2019 Oct;71(4):539-570. doi: 10.1124/pr.118.017129. Review.

PMID:
31537750
4.

Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP.

Reginauld SH, Cannone V, Iyer S, Scott C, Bailey K, Schaefer J, Chen Y, Sangaralingham SJ, Burnett JC Jr.

JACC Heart Fail. 2019 Oct;7(10):891-898. doi: 10.1016/j.jchf.2019.05.012. Epub 2019 Sep 11.

PMID:
31521687
5.

Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.

Lyle MA, Iyer SR, Redfield MM, Reddy YNV, Felker GM, Cappola TP, Hernandez AF, Scott CG, Burnett JC Jr, Pereira NL.

JACC Heart Fail. 2019 Aug 7. pii: S2213-1779(19)30549-9. doi: 10.1016/j.jchf.2019.07.005. [Epub ahead of print]

PMID:
31392960
6.

Atrial Natriuretic Peptide, Heart Failure and the Heart as an Endocrine Organ.

Burnett JC Jr.

Clin Chem. 2019 Jul 30. pii: clinchem.2019.308106. doi: 10.1373/clinchem.2019.308106. [Epub ahead of print] No abstract available.

PMID:
31362934
7.

Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease.

Reddy YNV, Iyer SR, Scott CG, Rodeheffer RJ, Bailey K, Jenkins G, Batzler A, Redfield MM, Burnett JC Jr, Pereira NL.

J Am Heart Assoc. 2019 Aug 6;8(15):e012943. doi: 10.1161/JAHA.119.012943. Epub 2019 Jul 26.

8.

Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy.

Peyser BD, Hermone A, Salamoun JM, Burnett JC, Hollingshead MG, McGrath CF, Gussio R, Wipf P.

Mol Cancer Ther. 2019 Oct;18(10):1765-1774. doi: 10.1158/1535-7163.MCT-19-0185. Epub 2019 Jul 24.

PMID:
31341033
9.

Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors.

Tasker NR, Rastelli EJ, Burnett JC, Sharlow ER, Lazo JS, Wipf P.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2008-2015. doi: 10.1016/j.bmcl.2019.06.048. Epub 2019 Jun 27. Review.

PMID:
31307888
10.

Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease.

Cannone V, Cabassi A, Volpi R, Burnett JC; Jr.

Int J Mol Sci. 2019 Jul 2;20(13). pii: E3265. doi: 10.3390/ijms20133265. Review.

11.

Do Zebrafish Obey Lipinski Rules?

Long K, Kostman SJ, Fernandez C, Burnett JC, Huryn DM.

ACS Med Chem Lett. 2019 Apr 24;10(6):1002-1006. doi: 10.1021/acsmedchemlett.9b00063. eCollection 2019 Jun 13.

PMID:
31223462
12.

Discovery of O-glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor.

Hansen LH, Madsen TD, Goth CK, Clausen H, Chen Y, Dzhoyashvili N, Iyer SR, Sangaralingham SJ, Burnett JC Jr, Rehfeld JF, Vakhrushev SY, Schjoldager KT, Goetze JP.

J Biol Chem. 2019 Aug 23;294(34):12567-12578. doi: 10.1074/jbc.RA119.008102. Epub 2019 Jun 11.

13.

NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis.

Yang S, Huang S, Daniels LB, Yeboah J, Lima JAC, Cannone V, Burnett JC Jr, Beckman JA, Carr JJ, Wang TJ, Gupta DK.

Heart. 2019 Oct;105(20):1590-1596. doi: 10.1136/heartjnl-2019-314707. Epub 2019 May 31.

PMID:
31152069
14.

C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.

Chen Y, Zheng Y, Iyer SR, Harders GE, Pan S, Chen HH, Ichiki T, Burnett JC Jr, Sangaralingham SJ.

J Mol Cell Cardiol. 2019 May;130:140-150. doi: 10.1016/j.yjmcc.2019.03.024. Epub 2019 Apr 4.

PMID:
30954448
15.

CRRL269.

Chen Y, Harty GJ, Zheng Y, Iyer SR, Sugihara S, Sangaralingham SJ, Ichiki T, Grande JP, Lee HC, Wang X, Burnett JC Jr.

Circ Res. 2019 May 10;124(10):1462-1472. doi: 10.1161/CIRCRESAHA.118.314164.

PMID:
30929579
16.

C-type natriuretic peptide: the heart's guardian angel.

Sangaralingham SJ, Chen Y, Burnett JC.

Eur Heart J. 2019 Mar 25. pii: ehz142. doi: 10.1093/eurheartj/ehz142. [Epub ahead of print] No abstract available.

PMID:
30907411
17.

Effect of Testosterone on Natriuretic Peptide Levels.

Bachmann KN, Huang S, Lee H, Dichtel LE, Gupta DK, Burnett JC Jr, Miller KK, Wang TJ, Finkelstein JS.

J Am Coll Cardiol. 2019 Mar 26;73(11):1288-1296. doi: 10.1016/j.jacc.2018.12.062.

PMID:
30898204
18.

Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.

Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, Apple FS, Burnett JC Jr, Iyer S, Januzzi JL Jr.

J Am Coll Cardiol. 2019 Mar 26;73(11):1273-1284. doi: 10.1016/j.jacc.2018.12.063.

PMID:
30898202
19.

Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide.

Meems LMG, Andersen IA, Pan S, Harty G, Chen Y, Zheng Y, Harders GE, Ichiki T, Heublein DM, Iyer SR, Sangaralingham SJ, McCormick DJ, Burnett JC Jr.

Hypertension. 2019 Apr;73(4):900-909. doi: 10.1161/HYPERTENSIONAHA.118.12012.

PMID:
30798663
20.

In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitors.

Tasker NR, Rastelli EJ, Blanco IK, Burnett JC, Sharlow ER, Lazo JS, Wipf P.

Org Biomol Chem. 2019 Feb 27;17(9):2448-2466. doi: 10.1039/c9ob00025a.

PMID:
30746541
21.

Relaxing With C-Type Natriuretic Peptide, the Guanylyl Cyclase B Receptor, and Pericytes.

Sangaralingham SJ, Burnett JC Jr.

Circulation. 2018 Jul 31;138(5):509-512. doi: 10.1161/CIRCULATIONAHA.118.035132. No abstract available.

22.

Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review.

Oatmen KE, Zile MR, Burnett JC Jr, Spinale FG.

JAMA Cardiol. 2018 Dec 1;3(12):1232-1243. doi: 10.1001/jamacardio.2018.3789. Review.

PMID:
30484834
23.

Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97.

LaPorte MG, Burnett JC, Colombo R, Bulfer SL, Alverez C, Chou TF, Neitz RJ, Green N, Moore WJ, Yue Z, Li S, Arkin MR, Wipf P, Huryn DM.

ACS Med Chem Lett. 2018 Sep 18;9(11):1075-1081. doi: 10.1021/acsmedchemlett.8b00372. eCollection 2018 Nov 8.

24.

Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.

Cannone V, Buglioni A, Sangaralingham SJ, Scott C, Bailey KR, Rodeheffer R, Redfield MM, Sarzani R, Burnett JC Jr.

Mayo Clin Proc. 2018 Aug;93(8):980-990. doi: 10.1016/j.mayocp.2018.05.027.

25.

Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide.

Ichiki T, Dzhoyashvili N, Burnett JC Jr.

Int J Cardiol. 2019 Apr 15;281:166-171. doi: 10.1016/j.ijcard.2018.06.002. Epub 2018 Jun 3.

26.

Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles.

Arizala JAC, Takahashi M, Burnett JC, Ouellet DL, Li H, Rossi JJ.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):961-981. doi: 10.1089/AID.2017.0306. Epub 2018 Jul 5.

27.

Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications.

Chen Y, Burnett JC.

Int J Mol Sci. 2018 Mar 27;19(4). pii: E1006. doi: 10.3390/ijms19041006. Review.

28.

Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor.

McQueeney KE, Salamoun JM, Burnett JC, Barabutis N, Pekic P, Lewandowski SL, Llaneza DC, Cornelison R, Bai Y, Zhang ZY, Catravas JD, Landen CN, Wipf P, Lazo JS, Sharlow ER.

Oncotarget. 2017 Dec 30;9(9):8223-8240. doi: 10.18632/oncotarget.23787. eCollection 2018 Feb 2.

29.

HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.

Satheesan S, Li H, Burnett JC, Takahashi M, Li S, Wu SX, Synold TW, Rossi JJ, Zhou J.

J Virol. 2018 Mar 14;92(7). pii: e02118-17. doi: 10.1128/JVI.02118-17. Print 2018 Apr 1.

30.

HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 20 Cities, United States, 2015.

Burnett JC, Broz D, Spiller MW, Wejnert C, Paz-Bailey G.

MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):23-28. doi: 10.15585/mmwr.mm6701a5.

31.

A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA).

Cannone V, Scott CG, Decker PA, Larson NB, Palmas W, Taylor KD, Wang TJ, Gupta DK, Bielinski SJ, Burnett JC Jr.

PLoS One. 2017 Dec 18;12(12):e0189858. doi: 10.1371/journal.pone.0189858. eCollection 2017.

32.

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure.

Kawakami R, Lee CYW, Scott C, Bailey KR, Schirger JA, Chen HH, Benike SL, Cannone V, Martin FL, Sangaralingham SJ, Ichiki T, Burnett JC Jr.

Clin Pharmacol Ther. 2018 Sep;104(3):546-552. doi: 10.1002/cpt.974. Epub 2018 Jan 11.

33.

CRRL269: a novel designer and renal-enhancing pGC-A peptide activator.

Chen Y, Harty GJ, Huntley BK, Iyer SR, Heublein DM, Harders GE, Meems L, Pan S, Sangaralingham SJ, Ichiki T, Burnett JC Jr.

Am J Physiol Regul Integr Comp Physiol. 2018 Mar 1;314(3):R407-R414. doi: 10.1152/ajpregu.00286.2017. Epub 2017 Nov 29.

34.

Small molecule targeting of PTPs in cancer.

Lazo JS, McQueeney KE, Burnett JC, Wipf P, Sharlow ER.

Int J Biochem Cell Biol. 2018 Mar;96:171-181. doi: 10.1016/j.biocel.2017.09.011. Epub 2017 Sep 21. Review.

PMID:
28943273
35.

Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis).

Gupta DK, Daniels LB, Cheng S, deFilippi CR, Criqui MH, Maisel AS, Lima JA, Bahrami H, Greenland P, Cushman M, Tracy R, Siscovick D, Bertoni AG, Cannone V, Burnett JC, Carr JJ, Wang TJ.

Am J Cardiol. 2017 Sep 15;120(6):1008-1015. doi: 10.1016/j.amjcard.2017.06.030. Epub 2017 Jun 30.

36.

BLAST-AHF: insights into biased AT1 ligands and heart failure. Beginning of the end or end of the beginning?

Sugihara S, Burnett JC Jr.

Eur Heart J. 2017 Aug 7;38(30):2374-2376. doi: 10.1093/eurheartj/ehx276. No abstract available.

37.

Atrial Natriuretic Peptide - Old But New Therapeutic in Cardiovascular Diseases.

Ichiki T, Burnett JC Jr.

Circ J. 2017 Jun 23;81(7):913-919. doi: 10.1253/circj.CJ-17-0499. Epub 2017 May 27. Review.

38.

Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.

Saiki H, Moulay G, Guenzel AJ, Liu W, Decklever TD, Classic KL, Pham L, Chen HH, Burnett JC, Russell SJ, Redfield MM.

Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H392-H407. doi: 10.1152/ajpheart.00124.2017. Epub 2017 May 26.

39.

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling.

Ichiki T, Huntley BK, Harty GJ, Sangaralingham SJ, Burnett JC Jr.

Physiol Rep. 2017 May;5(9). pii: e13283. doi: 10.14814/phy2.13283. Epub 2017 May 15.

40.

Innovative Therapeutics: Designer Natriuretic Peptides.

Meems LMG, Burnett JC Jr.

JACC Basic Transl Sci. 2016 Dec;1(7):557-567. doi: 10.1016/j.jacbts.2016.10.001.

41.

A threonine turnstile defines a dynamic amphiphilic binding motif in the AAA ATPase p97 allosteric binding site.

Burnett JC, Lim C, Peyser BD, Samankumara LP, Kovaliov M, Colombo R, Bulfer SL, LaPorte MG, Hermone AR, McGrath CF, Arkin MR, Gussio R, Huryn DM, Wipf P.

Org Biomol Chem. 2017 May 16;15(19):4096-4114. doi: 10.1039/c7ob00526a.

42.

Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism.

Glöde A, Naumann J, Gnad T, Cannone V, Kilic A, Burnett JC Jr, Pfeifer A.

Mol Metab. 2017 Jan 4;6(3):276-287. doi: 10.1016/j.molmet.2016.12.010. eCollection 2017 Mar.

43.

Neurohumoral Modulation During Waon Therapy in Chronic Heart Failure - Subanalysis of Waon-CHF Study.

Ichiki T, Burnett JC Jr, Scott CG, Heublein DM, Miyata M, Kinugawa K, Inoue T, Tei C; WAON-CHF Study Investigators.

Circ J. 2017 Apr 25;81(5):709-716. doi: 10.1253/circj.CJ-16-1117. Epub 2017 Feb 16.

44.

Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease.

Chen Y, Burnett JC Jr.

Clin Chem. 2017 Jan;63(1):108-115. doi: 10.1373/clinchem.2016.262907. Epub 2016 Nov 15. Review.

45.

NT-proBNP: The Gold Standard Biomarker in Heart Failure.

McKie PM, Burnett JC Jr.

J Am Coll Cardiol. 2016 Dec 6;68(22):2437-2439. doi: 10.1016/j.jacc.2016.10.001. No abstract available.

46.

Biomarker-based risk prediction in the community.

AbouEzzeddine OF, McKie PM, Scott CG, Rodeheffer RJ, Chen HH, Michael Felker G, Jaffe AS, Burnett JC, Redfield MM.

Eur J Heart Fail. 2016 Nov;18(11):1342-1350. doi: 10.1002/ejhf.663.

47.

High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency.

Takahashi M, Wu X, Ho M, Chomchan P, Rossi JJ, Burnett JC, Zhou J.

Sci Rep. 2016 Sep 22;6:33697. doi: 10.1038/srep33697.

48.

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.

Lee CY, Huntley BK, McCormick DJ, Ichiki T, Sangaralingham SJ, Lisy O, Burnett JC Jr.

Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):98-105. doi: 10.1093/ehjcvp/pvv040. Epub 2015 Dec 10.

49.

Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females.

Holditch SJ, Schreiber CA, Burnett JC, Ikeda Y.

Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623.

50.

Insulin/glucose induces natriuretic peptide clearance receptor in human adipocytes: a metabolic link with the cardiac natriuretic pathway.

Bordicchia M, Ceresiani M, Pavani M, Minardi D, Polito M, Wabitsch M, Cannone V, Burnett JC Jr, Dessì-Fulgheri P, Sarzani R.

Am J Physiol Regul Integr Comp Physiol. 2016 Jul 1;311(1):R104-14. doi: 10.1152/ajpregu.00499.2015. Epub 2016 Apr 13.

Supplemental Content

Loading ...
Support Center